Search

Andreas Verras

from New York, NY
Age ~48
Get Report
Also known as:
Andrew Verras, Andy Verras
Phone and address:
250 W 27Th St APT 6B, New York, NY 10001
Related to:
Stathis VerrasIoanna A Verras, 71Andy VerrasAthanasios Verras, 76
Connected to:
Cassandra L Verras, 41Andrea E Verrastro, 49Anthony T Verrastro, 58Aric R Verrastro, 39Kevin Verrastro, 54Lisa J Verrastro, 45Pasquale T Verrastro, 66Robert S Verrastro, 53Thomas F Verrastro, 54Jack T Verravas, 83

Andreas Verras Phones & Addresses

  • 250 W 27Th St APT 6B, New York, NY 10001
  • Atlanta, GA
  • San Francisco, CA
  • Brooklyn, NY
  • Rahway, NJ
  • 2935 Tall Pines Way NE, Atlanta, GA 30345

Work

Company: Merck Apr 2008 Position: Computational chemist

Education

Degree: Doctorate School / High School: University of California, San Francisco 1998 to 2004 Specialities: Chemistry and Chemical Biology

Skills

Virtual Screening • Cheminformatics • Computational Chemistry • Drug Design • Drug Discovery • Lead Optimization • Qsar • Bioinformatics • Homology Modeling • Molecular Dynamics • R • Docking • Life Sciences • Chemistry • Library Design • Molecular Modeling • Machine Learning • Data Analysis • Data Mining • Python • Science • Programming • Perl • Linux • Research • Statistics • Spotfire • Informatics • Gpcrs • Adme • Lead Change • Biochemistry

Industries

Computer Software

Resumes

Resumes

Andreas Verras Photo 1

Principal Scientist

View page
Location:
New York, NY
Industry:
Computer Software
Work:
Merck since Apr 2008
Computational Chemist
Syngenta Crop Protection Oct 2005 - Mar 2008
Computational Chemist
UCSF 1998 - 2004
Graduate Researcher
Education:
University of California, San Francisco 1998 - 2004
Doctorate, Chemistry and Chemical Biology Emory University 1994 - 1998
BS, BA, Chemistry, Creative Writing
Skills:
Virtual Screening
Cheminformatics
Computational Chemistry
Drug Design
Drug Discovery
Lead Optimization
Qsar
Bioinformatics
Homology Modeling
Molecular Dynamics
R
Docking
Life Sciences
Chemistry
Library Design
Molecular Modeling
Machine Learning
Data Analysis
Data Mining
Python
Science
Programming
Perl
Linux
Research
Statistics
Spotfire
Informatics
Gpcrs
Adme
Lead Change
Biochemistry

Publications

Us Patents

Isothiazole And Pyrazole Derivatives As Fungicides

View page
US Patent:
8377953, Feb 19, 2013
Filed:
Jul 9, 2008
Appl. No.:
12/668435
Inventors:
Peter Ackermann - Pfeffingen, CH
Carla Bobbio - Stein, CH
Camilla Corsi - Stein, CH
Ann Monica McGinley - Riehen, CH
Andreas Verras - New York NY, US
Ruud Titulaeu - Nijmegen, NL
Josef Ehrenfreund - Allschwil, CH
Assignee:
Syngenta Crop Protection LLC - Greensboro NC
International Classification:
A61K 31/506
A61K 31/4439
A01N 43/56
A01N 43/80
A01P 3/00
A61P 31/10
C07D 401/06
C07D 417/06
US Classification:
514269
Abstract:
The present invention relates to compounds of Formula (I) wherein R, R, Ror Rare as defined in claim or a salt or N-oxide thereof and their use in methods for the control and/or prevention of fungal infection, particularly in plants. The compounds claimed are isothiazole and pyrazole derivatives.

Compound Having Kdm5 Inhibitory Activity And Pharmaceutical Use Thereof

View page
US Patent:
20220289751, Sep 15, 2022
Filed:
Jul 16, 2020
Appl. No.:
17/623706
Inventors:
- Osaka-shi, Osaka, JP
Shuhei UMEMURA - Osaka, JP
Mats SVENSSON - New York NY, US
Anatoly RUVINSKY - Lexington MA, US
Daigo INOYAMA - Edgewater NJ, US
Goran KRILOV - Long Island City NY, US
Hidenori TAKAHASHI - Lagrangeville NY, US
Kyle KONZE - Brooklyn NY, US
Andreas VERRAS - New York NY, US
Simon CRUMPLER - Saffron Walden, GB
Maelle VALLADE - Saffron Walden, GB
Calum MACLEOD - Saffron Walden, GB
James N. SANDERSON - Saffron Walden, GB
Richard J. BULL - Saffron Walden, GB
Simon GAINES - Saffron Walden, GB
Assignee:
ONO PHARMACEUTICAL CO., LTD. - Osaka-shi, Osaka
International Classification:
C07D 487/04
A61K 31/53
C07D 471/04
A61K 31/519
C07D 401/14
A61K 31/4439
C07D 487/10
A61K 31/4155
A61K 31/427
C07D 403/12
Abstract:
The compound disclosed is a KDM5 inhibitor represented by the general formula (Z):wherein all symbols have the same meanings as the definitions described in the specification, or a salt thereof, and is useful as a prophylactic and/or therapeutic agent for cancer, Huntington's disease, or Alzheimer's disease and the like.

Ctps1 Inhibitors And Uses Thereof

View page
US Patent:
20230077316, Mar 9, 2023
Filed:
Oct 22, 2021
Appl. No.:
17/452011
Inventors:
- Cambridge MA, US
Lewis Whitehead - Swampscott MA, US
Angela V. West - Franklin MA, US
Steven K. Albanese - Brooklyn NY, US
Andreas Verras - New York NY, US
Shaughnessy Robinson - Westerly RI, US
Neelu Kaila - Lexington MA, US
Sebastien Campos - Hoddesdon, GB
Kevin Demarco - New York NY, US
International Classification:
C07D 417/14
C07D 277/52
C07D 417/12
C07D 401/14
C07D 401/04
C07D 401/12
C07D 413/14
C07D 241/18
C07D 417/04
C07D 471/04
C07D 403/14
C07D 498/08
Abstract:
The present invention provides compounds, compositions thereof, and methods of using the same for the inhibition of CPTS1, and the treatment of CPTS1-mediated disorders.

Novel Substituted Piperazine Amide Compounds As Indoleamine 2,3-Dioxygenase (Ido) Inhibitors

View page
US Patent:
20230008022, Jan 12, 2023
Filed:
Nov 25, 2019
Appl. No.:
17/295497
Inventors:
Dane CLAUSEN - Kenilworth NJ, US
Ping CHEN - Kenilworth NJ, US
Xavier FRADERA - Boston MA, US
Liangqin GUO - Kenilworth NJ, US
Yongxin HAN - Boston MA, US
Shuwen HE - Fanwood NJ, US
Xianhai HUANG - Warren NJ, US
Joseph KOZLOWSKI - Princeton NJ, US
Guoqing LI - Kenilworth NJ, US
Theodore A. MARTINOT - Southborough MA, US
Alexander PASTERNAK - Boston MA, US
Andreas VERRAS - New York NY, US
Li XIAO - Kenilworth NJ, US
Wensheng YU - Kenilworth NJ, US
Rui ZHANG - Kenilworth NJ, US
- Rahway NJ, US
Assignee:
Merck Sharp & Dohme Corp. - Rahway NJ
International Classification:
C07D 231/56
C07D 491/052
C07D 231/54
A61K 31/496
C07D 401/12
C07D 401/14
C07D 413/12
A61K 31/5377
C07D 498/10
C07D 491/107
C07D 498/08
C07D 471/10
C07D 403/12
C07D 405/12
C07D 498/04
C07D 487/04
C07D 487/10
A61K 31/541
C07D 413/14
Abstract:
Disclosed herein are compounds of formula (I) which are inhibitors of an IDO enzyme: (I). Also disclosed herein are uses of the compounds in the potential treatment or prevention of an IDO-associated disease or disorder. Also disclosed herein are compositions comprising these compounds. Further disclosed herein are uses of the compositions in the potential treatment or prevention of an IDO-associated disease or disorder.

Novel Aryloxypiperidine Pyrazole Compounds As Indoleamine 2,3-Dioxygenase Inhibitors

View page
US Patent:
20210330676, Oct 28, 2021
Filed:
Aug 16, 2019
Appl. No.:
17/268995
Inventors:
- Rahway NJ, US
Xavier Fradera - Brookline MA, US
Liangqin Guo - Monroe NJ, US
Yongxin Han - Needham MA, US
Shuwen He - Fanwood NJ, US
Xianhai Huang - Warren NJ, US
Joseph Kozlowski - Princeton NJ, US
Guoqing Li - Belle Mead NJ, US
Jongwon Lim - Lexington MA, US
Theodore A. Martinot - Southborough MA, US
Alexander Pasternak - Jamaica Plain MA, US
Nunzio Sciammetta - Sudbury MA, US
Andreas Verras - New York NY, US
Li Xiao - Cranbury NJ, US
Wensheng Yu - Edison NJ, US
Rui Zhang - Plainsboro NJ, US
Assignee:
Merck Sharp & Dohme Corp. - Rahway NJ
International Classification:
A61K 31/5377
A61K 45/06
C07D 401/14
C07D 401/06
C07D 413/14
C07D 451/06
A61K 31/4545
A61K 31/496
A61K 31/454
A61K 31/46
Abstract:
Disclosed herein are compounds of formula (I) which are inhibitors of an IDO enzyme: Also disclosed herein are uses of the compounds in the potential treatment or prevention of an IDO-associated disease or disorder. Also disclosed herein are compositions comprising these compounds. Further disclosed herein are uses of the compositions in the potential treatment or prevention of an IDO-associated disease or disorder.

Indazole Derivatives Useful As Inhibitors Of Diacylglyceride O-Acyltransferase 2

View page
US Patent:
20190330239, Oct 31, 2019
Filed:
Nov 13, 2017
Appl. No.:
16/461902
Inventors:
Thomas H. Graham - Boston MA, US
Wensheng LIU - Edison NJ, US
Clare TUDGE - Chatham NJ, US
Andreas VERRAS - New York NY, US
Jinlong JIANG - Kenilworth NJ, US
- Rahway NJ, US
Assignee:
Merck Sharp & Dohme Corp. - Rahway NJ
International Classification:
C07D 515/08
C07D 409/12
C07D 401/12
C07D 403/12
C07D 231/56
C07D 405/12
C07D 487/04
C07D 417/12
C07D 413/12
C07D 409/14
Abstract:
The present invention relates to a compound represented by formula I′: and pharmaceutically acceptable salts thereof. The compounds of formula I are inhibitors of diacylglyceride O-acyltransferase 2 (“DGAT2”) and may be useful in the treatment, prevention and suppression of diseases mediated by DGAT2. The compounds of the present invention may be useful in the treatment of hepatic steatosis, diabetes mellitus, obesity, hyperlipidemia, hypercholesterolemia, atherosclerosis, cardiorenal diseases such as chronic kidney diseases and heart failure and related diseases and conditions.

Compounds Useful For Altering The Levels Of Bile Acids For The Treatment Of Diabetes And Cardiometabolc Disease

View page
US Patent:
20190218224, Jul 18, 2019
Filed:
Aug 10, 2017
Appl. No.:
16/324604
Inventors:
- Rahway NJ, US
Mary Ann Caplen - Sayreville NJ, US
Jared N. Cumming - Garwood NJ, US
Kevin D. Dykstra - West Milford NJ, US
Alan Hruza - Hackettstown NJ, US
Claire Lankin - High Bridge NJ, US
Derun Li - Scotch Plains NJ, US
Hong Liu - Hillsborough NJ, US
Amy McCracken - Berkeley Heights NJ, US
Brian McKittrick - New Vernon NJ, US
Ashwin Rao - Morganville NH, US
Jayaram Tagat - Westfield NJ, US
Haiqun Tang - Belle Mead NJ, US
Brandon M. Taoka - Hoboken NJ, US
Andreas Verras - New York NY, US
Shawn P. Walsh - Bridgewater NJ, US
Tianyuan Zhang - Edison NJ, US
Assignee:
Merck Sharp & Dohme Corp. - Rahway NJ
International Classification:
C07D 487/04
C07D 519/00
C07D 498/04
Abstract:
Described herein are compounds of Formula I or a pharmaceutically acceptable salt thereof. The compounds of Formula I act as Cyp8b1 inhibitors and can be useful in preventing, treating or acting as a remedial agent for diabetes and cardiovascular disease.
Control profile
Andreas Verras from New York, NY, age ~48 Get Report